Reported side effects are rare and mild , but may include: Temporary injection site redness Headache or fatigue (usually transient) Mild dizziness during first doses Importantly, Epithalon is not FDA-approved for any condition and is used for research purposes only under the direction of a licensed provider
This study was approved by the appropriate ethical committees indicated above CPP and CNIL (Biological Research & Collection BRC Identification number: 2020-A00478-31)
Butyrate production in phylogenetically diverse firmicutes isolated from the chicken caecum
The integration of circularity and sustainability with social justice and innovation in urban development
Your Health Basket provides access to nutritional guidance through qualified practitioners
To view a copy of this licence, visit About this article Cite this article Zhong, M., Wang, Y., Min, J